FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2132235470> ?p ?o ?g. }

• W2132235470 endingPage "196" @default.
• W2132235470 startingPage "191" @default.
• W2132235470 abstract "Purpose To describe the prevalence of fat and muscle volume (MV) increase in Graves' orbitopathy (GO) patients, calculated from computed tomography scans, and the associated ophthalmic and endocrine characteristics. Design Consecutive, observational case series. Participants Ninety-five consecutive Caucasian GO patients attending the thyroid eye clinic. Methods Volumetry using age-specific reference values in untreated GO patients who had been rendered euthyroid. Main Outcome Measures Subgroups in GO and main characteristics. Results Four subgroups could be distinguished: Group 1, no fat volume (FV) or MV increase (n = 24); group 2, only FV increase (n = 5); group 3, only MV increase (n = 58); and group 4, both FV and MV increase (n = 8). Patients with an increase of MV were older and had higher thyroid-stimulating hormone–binding inhibitory immunoglobulin TBII, more proptosis, and more impaired ductions than those without MV increase. Patients with an increase of FV differed from those without FV increase only in having more proptosis. The clinical activity score did not differ between the 4 groups. Conclusions Of these GO patients, 25% have orbital fat and MVs within an age-specific reference range. An increase of the FV is seen in only 14% of GO patients and characterized by proptosis. Muscle enlargement occurs in 70% of patients and is associated with older age, higher TBII values, more proptosis, and impaired motility. Financial Disclosure(s) The authors have no proprietary or commercial interest in any of the materials discussed in this article. To describe the prevalence of fat and muscle volume (MV) increase in Graves' orbitopathy (GO) patients, calculated from computed tomography scans, and the associated ophthalmic and endocrine characteristics. Consecutive, observational case series. Ninety-five consecutive Caucasian GO patients attending the thyroid eye clinic. Volumetry using age-specific reference values in untreated GO patients who had been rendered euthyroid. Subgroups in GO and main characteristics. Four subgroups could be distinguished: Group 1, no fat volume (FV) or MV increase (n = 24); group 2, only FV increase (n = 5); group 3, only MV increase (n = 58); and group 4, both FV and MV increase (n = 8). Patients with an increase of MV were older and had higher thyroid-stimulating hormone–binding inhibitory immunoglobulin TBII, more proptosis, and more impaired ductions than those without MV increase. Patients with an increase of FV differed from those without FV increase only in having more proptosis. The clinical activity score did not differ between the 4 groups. Of these GO patients, 25% have orbital fat and MVs within an age-specific reference range. An increase of the FV is seen in only 14% of GO patients and characterized by proptosis. Muscle enlargement occurs in 70% of patients and is associated with older age, higher TBII values, more proptosis, and impaired motility." @default.
• W2132235470 created "2016-06-24" @default.
• W2132235470 creator A5017838181 @default.
• W2132235470 creator A5036895475 @default.
• W2132235470 creator A5054476844 @default.
• W2132235470 creator A5066249415 @default.
• W2132235470 creator A5089110123 @default.
• W2132235470 date "2011-01-01" @default.
• W2132235470 modified "2023-10-17" @default.
• W2132235470 title "Do Subtypes of Graves' Orbitopathy Exist?" @default.
• W2132235470 cites W1986208226 @default.
• W2132235470 cites W2011173729 @default.
• W2132235470 cites W2017252516 @default.
• W2132235470 cites W2024513447 @default.
• W2132235470 cites W2032292783 @default.
• W2132235470 cites W2034104631 @default.
• W2132235470 cites W2063823126 @default.
• W2132235470 cites W2072447280 @default.
• W2132235470 cites W2087738483 @default.
• W2132235470 cites W2089992103 @default.
• W2132235470 cites W2091950481 @default.
• W2132235470 cites W2103435787 @default.
• W2132235470 cites W2144470478 @default.
• W2132235470 cites W2313887106 @default.
• W2132235470 cites W2316573558 @default.
• W2132235470 cites W2426290758 @default.
• W2132235470 doi "https://doi.org/10.1016/j.ophtha.2010.04.004" @default.
• W2132235470 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20673587" @default.
• W2132235470 hasPublicationYear "2011" @default.
• W2132235470 type Work @default.
• W2132235470 sameAs 2132235470 @default.
• W2132235470 citedByCount "64" @default.
• W2132235470 countsByYear W21322354702012 @default.
• W2132235470 countsByYear W21322354702013 @default.
• W2132235470 countsByYear W21322354702014 @default.
• W2132235470 countsByYear W21322354702015 @default.
• W2132235470 countsByYear W21322354702016 @default.
• W2132235470 countsByYear W21322354702017 @default.
• W2132235470 countsByYear W21322354702018 @default.
• W2132235470 countsByYear W21322354702019 @default.
• W2132235470 countsByYear W21322354702020 @default.
• W2132235470 countsByYear W21322354702021 @default.
• W2132235470 countsByYear W21322354702022 @default.
• W2132235470 countsByYear W21322354702023 @default.
• W2132235470 crossrefType "journal-article" @default.
• W2132235470 hasAuthorship W2132235470A5017838181 @default.
• W2132235470 hasAuthorship W2132235470A5036895475 @default.
• W2132235470 hasAuthorship W2132235470A5054476844 @default.
• W2132235470 hasAuthorship W2132235470A5066249415 @default.
• W2132235470 hasAuthorship W2132235470A5089110123 @default.
• W2132235470 hasConcept C126322002 @default.
• W2132235470 hasConcept C134018914 @default.
• W2132235470 hasConcept C187212893 @default.
• W2132235470 hasConcept C2776652619 @default.
• W2132235470 hasConcept C2776685619 @default.
• W2132235470 hasConcept C2777195454 @default.
• W2132235470 hasConcept C46699223 @default.
• W2132235470 hasConcept C526584372 @default.
• W2132235470 hasConcept C71315377 @default.
• W2132235470 hasConcept C71924100 @default.
• W2132235470 hasConceptScore W2132235470C126322002 @default.
• W2132235470 hasConceptScore W2132235470C134018914 @default.
• W2132235470 hasConceptScore W2132235470C187212893 @default.
• W2132235470 hasConceptScore W2132235470C2776652619 @default.
• W2132235470 hasConceptScore W2132235470C2776685619 @default.
• W2132235470 hasConceptScore W2132235470C2777195454 @default.
• W2132235470 hasConceptScore W2132235470C46699223 @default.
• W2132235470 hasConceptScore W2132235470C526584372 @default.
• W2132235470 hasConceptScore W2132235470C71315377 @default.
• W2132235470 hasConceptScore W2132235470C71924100 @default.
• W2132235470 hasIssue "1" @default.
• W2132235470 hasLocation W21322354701 @default.
• W2132235470 hasLocation W21322354702 @default.
• W2132235470 hasOpenAccess W2132235470 @default.
• W2132235470 hasPrimaryLocation W21322354701 @default.
• W2132235470 hasRelatedWork W165683302 @default.
• W2132235470 hasRelatedWork W1975243593 @default.
• W2132235470 hasRelatedWork W204360474 @default.
• W2132235470 hasRelatedWork W2198422159 @default.
• W2132235470 hasRelatedWork W2361103787 @default.
• W2132235470 hasRelatedWork W2444221640 @default.
• W2132235470 hasRelatedWork W2791908257 @default.
• W2132235470 hasRelatedWork W2895682731 @default.
• W2132235470 hasRelatedWork W3032608546 @default.
• W2132235470 hasRelatedWork W3201437197 @default.
• W2132235470 hasVolume "118" @default.
• W2132235470 isParatext "false" @default.
• W2132235470 isRetracted "false" @default.
• W2132235470 magId "2132235470" @default.
• W2132235470 workType "article" @default.